DIMENSIONAL FUND ADVISORS LP - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 90 filers reported holding FATE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,516,237
+55.6%
715,149
+249.3%
0.00%
Q2 2023$974,536
-51.1%
204,726
-41.4%
0.00%
-100.0%
Q1 2023$1,991,506
+35692.7%
349,529
-36.6%
0.00%
-50.0%
Q4 2022$5,564
-99.9%
551,469
+130.1%
0.00%0.0%
Q3 2022$5,371,000
-18.9%
239,682
-10.3%
0.00%0.0%
Q2 2022$6,620,000
-56.1%
267,166
-31.3%
0.00%
-60.0%
Q1 2022$15,088,000
-37.8%
389,116
-6.1%
0.01%
-28.6%
Q4 2021$24,254,000
+28.2%
414,477
+29.9%
0.01%
+16.7%
Q3 2021$18,912,000
+70.1%
319,069
+149.1%
0.01%
+50.0%
Q2 2021$11,117,000
+107.5%
128,065
+97.7%
0.00%
+100.0%
Q1 2021$5,357,000
+82.1%
64,762
+100.1%
0.00%
+100.0%
Q4 2020$2,942,000
+276.7%
32,358
+42.1%
0.00%
Q2 2020$781,000
+54.3%
22,7710.0%0.00%
Q1 2020$506,000
+7.7%
22,771
-5.1%
0.00%
Q4 2019$470,000
+76.7%
24,000
+2.1%
0.00%
Q2 2018$266,000
+16.2%
23,5000.0%0.00%
Q1 2018$229,000
+59.0%
23,5000.0%0.00%
Q4 2017$144,000
+54.8%
23,5000.0%0.00%
Q3 2017$93,000
+22.4%
23,5000.0%0.00%
Q2 2017$76,00023,5000.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$7,163,6162.64%
Redmile Group, LLC 13,124,427$27,823,7851.32%
Monaco Asset Management SAM 1,847,944$3,917,6411.16%
Casdin Capital, LLC 2,050,000$4,346,0000.48%
TANG CAPITAL MANAGEMENT LLC 700,000$1,484,0000.21%
GCM Grosvenor Holdings, LLC 495,916$1,051,3420.21%
Nebula Research & Development LLC 163,617$346,8680.18%
Bellevue Group AG 4,851,579$10,285,3470.17%
Bruce & Co., Inc. 200,000$424,0000.14%
XTX Topco Ltd 192,920$408,9900.07%
View complete list of FATE THERAPEUTICS INC shareholders